NES
GILD icon

New England Securities’s Gilead Sciences GILD Stock Holding History

New England Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$527K Buy
5,592
+2,727
+95% +$282K 0.18% 138
2014
Q3 		$305K Buy
2,865
+775
+37% +$75.9K 0.11% 205
2014
Q2 		$173K Buy
2,090
+883
+73% +$68.7K 0.06% 333
2014
Q1 		$86K Sell
1,207
-190
-14% -$14.9K 0.03% 417
2013
Q4 		$105K Buy
1,397
+25
+2% +$1.74K 0.04% 384
2013
Q3 		$86K Buy
1,372
+534
+64% +$31.9K 0.04% 386
2013
Q2 		$43K Buy
+838
New +$43.7K 0.03% 476

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Securities's GILD Position: Q4 2014 in Review

New England Securities increased its Gilead Sciences (GILD) stake by 95% in Q4 2014, buying an estimated $282K and bringing the position to 5,592 shares worth $527K. The position accounts for 0.18% of the portfolio, ranked #138.

New England Securities first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • New England Securities held 5,592 shares of Gilead Sciences worth $527K as of Q4 2014.
  • New England Securities bought 2,727 Gilead Sciences shares in Q4 2014, an estimated $282K.
  • Gilead Sciences made up 0.18% of New England Securities's portfolio in Q4 2014, its #138 holding.
  • New England Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.